2012
DOI: 10.1016/j.cyto.2011.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
15
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 150 publications
1
15
0
Order By: Relevance
“…Anti-TNF antibodies are an effective therapy for various inflammatory conditions such as rheumatoid arthritis (Vinay and Kwon 2012) and inflammatory bowel disease (Hering and Schulzke 2009). The use of anti-TNF therapy in CF is not routine, and in fact there are only three case reports in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…Anti-TNF antibodies are an effective therapy for various inflammatory conditions such as rheumatoid arthritis (Vinay and Kwon 2012) and inflammatory bowel disease (Hering and Schulzke 2009). The use of anti-TNF therapy in CF is not routine, and in fact there are only three case reports in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial hyperplasia and inflammatory cell recruitment eventually leading to destruction of cartilage and bone [1], [2]. It afflicts approximately 1% of the worldwide population [3].…”
Section: Introductionmentioning
confidence: 99%
“…Rheumatoid arthritis (RA) is a common, chronic, systemic, and inflammatory autoimmune disorder that primarily affects the small diarthrodial joints of the hands and feet, affecting approximately 1% of the world's population [13]. The main characteristics of this disease are synovium hyperplasia, lymphocyte infiltration, and the abnormal proliferation of fibroblast-like synoviocytes (FLS) that can lead to the destruction of bone and cartilage and eventual disability [4].…”
Section: Introductionmentioning
confidence: 99%